OCAM
REGN icon

Onex Canada Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Onex Canada Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,469
Closed -$932K – 123
2025
Q1 		$932K Sell
1,469
-750
-34% -$516K 0.12% 110
2024
Q4 		$1.58M Sell
2,219
-15
-0.7% -$12.6K 0.19% 97
2024
Q3 		$2.35M Hold
2,234
– – 0.27% 87
2024
Q2 		$2.35M Buy
2,234
+4
+0.2% +$3.88K 0.27% 100
2024
Q1 		$2.15M Sell
2,230
-202
-8% -$192K 0.21% 110
2023
Q4 		$2.14M Sell
2,432
-779
-24% -$642K 0.21% 117
2023
Q3 		$2.64M Sell
3,211
-408
-11% -$321K 0.2% 114
2023
Q2 		$2.6M Sell
3,619
-974
-21% -$751K 0.16% 119
2023
Q1 		$3.77M Sell
4,593
-2,239
-33% -$1.69M 0.21% 103
2022
Q4 		$4.93M Buy
6,832
+162
+2% +$120K 0.28% 96
2022
Q3 		$4.59M Sell
6,670
-65
-1% -$40.9K 0.27% 92
2022
Q2 		$3.98M Sell
6,735
-68
-1% -$44.2K 0.22% 103
2022
Q1 		$4.75M Buy
+6,803
New +$4.3M 0.21% 104

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Onex Canada Asset Management's REGN Position: Q2 2025 in Review

Onex Canada Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 1,469 shares — an estimated $932K sold.

Onex Canada Asset Management first reported a position in REGN in Q1 2022 and held it in 13 quarters. The position peaked at $4.93M in Q4 2022. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Onex Canada Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Onex Canada Asset Management sold 1,469 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $932K.
  • Onex Canada Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2022 and held it in 13 quarters.
  • Onex Canada Asset Management's Regeneron Pharmaceuticals position peaked at $4.93M in Q4 2022.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Onex Canada Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.